{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:14:09Z","timestamp":1794960849986,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118056","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T06:53:36Z","timestamp":1745736816000},"page":"118056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Contemporary insights into elamipretide\u2019s mitochondrial mechanism of action and therapeutic effects"],"prefix":"10.1016","volume":"187","author":[{"given":"Hani N.","family":"Sabbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan N.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve C.","family":"Sparagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-6089","authenticated-orcid":false,"given":"James E.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-7750","authenticated-orcid":false,"given":"Brian L.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-4148","authenticated-orcid":false,"given":"Luke H.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.S.","family":"Pitceathly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Marcinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2025.118056_bib1","first-page":"465","article-title":"Mitochondrial cristae architecture and functions: lessons from minimal model systems","volume":"11","author":"Joubert","year":"2021","journal-title":"Membr. (Basel)"},{"issue":"26","key":"10.1016\/j.biopha.2025.118056_bib2","doi-asserted-by":"crossref","first-page":"15363","DOI":"10.1073\/pnas.2002250117","article-title":"Mitochondrial protein interaction landscape of SS-31","volume":"117","author":"Chavez","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118056_bib3","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.biopha.2025.118056_bib4","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118056_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","article-title":"Mitochondria-penetrating peptides","volume":"15","author":"Horton","year":"2008","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24231-4","article-title":"Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice","volume":"12","author":"Russo","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib8","first-page":"554","article-title":"Reversible mitochondrial fragmentation in iPSC-derived cardiomyocytes from children with DCMA, a mitochondrial cardiomyopathy","volume":"36","author":"Rohani","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118056_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcvm.2019.00167","article-title":"SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts from patients with DCMA, a mitochondrial cardiomyopathy","volume":"6","author":"Machiraju","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42003-020-1101-3","article-title":"The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats","volume":"3","author":"Allen","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2025.118056_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.abb.2018.10.013","article-title":"Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging","volume":"660","author":"Szeto","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.biopha.2025.118056_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64368-y","article-title":"SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome","volume":"14","author":"Russo","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118056_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002206","article-title":"Chronic Therapy With Elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure","volume":"9","author":"Sabbah","year":"2016","journal-title":"Circ. Heart Fail"},{"issue":"6","key":"10.1016\/j.biopha.2025.118056_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003118","article-title":"Restoration of mitochondrial cardiolipin attenuates cardiac damage in swine renovascular hypertension","volume":"5","author":"Eirin","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1074248413508003","article-title":"Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia","volume":"19","author":"Brown","year":"2014","journal-title":"J. Cardiovasc Pharm. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2025.118056_bib17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118056_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2014.03.011","article-title":"Mitochondrial reactive oxygen species production and elimination","volume":"73","author":"Nickel","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118056_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118056_bib20","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","article-title":"Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis","volume":"171","author":"Birk","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"21","key":"10.1016\/j.biopha.2025.118056_bib21","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1074\/jbc.RA119.012094","article-title":"The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action","volume":"295","author":"Mitchell","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118056_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mito.2019.07.010","article-title":"Exploring the links between lipid geometry and mitochondrial fission: emerging concepts","volume":"49","author":"Agrawal","year":"2019","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"Paradies","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118056_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75531","article-title":"Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds","volume":"11","author":"Mitchell","year":"2022","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.biopha.2025.118056_bib25","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1021\/acs.molpharmaceut.3c00480","article-title":"Peptide power: mechanistic insights into the effect of mitochondria-targeted tetrapeptides on membrane electrostatics from molecular simulations","volume":"20","author":"Tamucci","year":"2023","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118056_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019892","article-title":"Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells","volume":"6","author":"Chavez","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cels.2017.10.017","article-title":"Chemical crosslinking mass spectrometry analysis of protein conformations and supercomplexes in heart tissue","volume":"6","author":"Chavez","year":"2018","journal-title":"Cell Syst."},{"issue":"3","key":"10.1016\/j.biopha.2025.118056_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cmet.2012.07.015","article-title":"NDUFA4 is a subunit of complex IV of the mammalian electron transport chain","volume":"16","author":"Balsa","year":"2012","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biopha.2025.118056_bib29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41422-018-0071-1","article-title":"Structure of the intact 14-subunit human cytochrome c oxidase","volume":"28","author":"Zong","year":"2018","journal-title":"Cell Res."},{"issue":"8019","key":"10.1016\/j.biopha.2025.118056_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41586-024-07488-9","article-title":"High-resolution in situ structures of mammalian respiratory supercomplexes","volume":"631","author":"Zheng","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118056_bib31","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.yjmcc.2020.05.012","article-title":"A 20\/20 view of ANT function in mitochondrial biology and necrotic cell death","volume":"144","author":"Bround","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118056_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s44161-022-00127-4","article-title":"Mitochondrial interactome quantitation reveals structural changes in metabolic machinery in the failing murine heart","volume":"1","author":"Caudal","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.118056_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60827","article-title":"Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte","volume":"9","author":"Zhang","year":"2020","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.biopha.2025.118056_bib34","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s11357-023-00861-y","article-title":"The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)","volume":"45","author":"Pharaoh","year":"2023","journal-title":"Geroscience"},{"issue":"5","key":"10.1016\/j.biopha.2025.118056_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acel.12102","article-title":"Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice","volume":"12","author":"Siegel","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2025.118056_bib36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2018.12.031","article-title":"Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice","volume":"134","author":"Campbell","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2025.118056_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253849","article-title":"In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial","volume":"16","author":"Roshanravan","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2217\/fca-2023-0008","article-title":"Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide","volume":"19","author":"Sabbah","year":"2023","journal-title":"Future Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-024-01860-1","article-title":"SS-31 inhibits mtDNA-cGAS-STING signaling to improve POCD by activating mitophagy in aged mice","volume":"73","author":"Ji","year":"2024","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118056_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","article-title":"Abnormalities of mitochondrial dynamics in the failing heart: normalization following long-term therapy with elamipretide","volume":"32","author":"Sabbah","year":"2018","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.biopha.2025.118056_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55513","article-title":"Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice","volume":"9","author":"Chiao","year":"2020","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.biopha.2025.118056_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118056_bib43","article-title":"Mitochondrial reactive oxygen species cause arrhythmias in hypertrophic cardiomyopathy","author":"Kohlhaas","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2025.118056_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ehf2.12408","article-title":"Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure","volume":"6","author":"Sabbah","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118056_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107701","article-title":"Age-related macular degeneration (AMD) mitochondria modulate epigenetic mechanisms in retinal pigment epithelial cells","volume":"189","author":"Nashine","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2025.118056_bib46","first-page":"1954","article-title":"Elamipretide protects RPE and improves mitochondrial function in models of AMD","volume":"58","author":"Kapphahn","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118056_bib47","first-page":"829","article-title":"The mitochondria-targeted peptide MTP-131 547 prevents hydroquinone-mediated persistent injury phenotype in cultured retinal pigment 548 epithelium cells","volume":"56","author":"Cousins","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118056_bib48","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048256","article-title":"Treatment of age-related visual impairment with a peptide acting on mitochondria","volume":"15","author":"Alam","year":"2022","journal-title":"Dis. Model Mech."},{"issue":"3","key":"10.1016\/j.biopha.2025.118056_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Thompson","year":"2021","journal-title":"Genet Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13023-022-02469-5","article-title":"Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome","volume":"17","author":"Hornby","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118056_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100628","article-title":"ReCLAIM-2: a randomized phase ii clinical trial evaluating elamipretide in age-related macular degeneration, geographic atrophy growth, visual function, and ellipsoid zone preservation","volume":"5","author":"Ehlers","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.biopha.2025.118056_bib52","unstructured":"Lally, D.R., Abbruscato A., Yordi S., Cetin H., Whitmore V., Karla G., Cakir Y., et al. Elamipretide-Mediated Visual Function Improvements Are Associated With Ellipsoid Zone Integrity in Patients With Geographic Atrophy. Presented at: Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. April 23-27, 2023; New Orleans, LA."},{"issue":"3","key":"10.1016\/j.biopha.2025.118056_bib53","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","article-title":"Efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy: the MMPOWER-3 randomized clinical trial","volume":"101","author":"Karaa","year":"2023","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118056_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best. Pr. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2025.118056_bib55","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","article-title":"Mitochondria at the crossroads of health and disease","volume":"187","author":"Suomalainen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118056_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.enz.2023.05.001","article-title":"The mitochondrial respiratory chain","volume":"54","author":"Wikstr\u00f6m","year":"2023","journal-title":"Enzymes"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:50:37Z","timestamp":1759002637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":56,"alternative-id":["S0753332225002501"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118056","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary insights into elamipretide\u2019s mitochondrial mechanism of action and therapeutic effects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118056"}}